Shannon Heaning, Content Associate

Phase 2 SkinJect data support the 200-µg dose and inform Medicus’ FDA-authorized registrational program in Gorlin syndrome.

A 3-patient case series explored photothermal biomodulated PRP with laser and LED therapy for acne-related erythema, hyperpigmentation, and scarring.

Dietary changes may help some patients with chronic urticaria, but evidence does not yet support a standardized diet.

James Caleb Runyon, MSN, APRN, FNP-C, discussed how his Closer Look Project trains personal care professionals to recognize signs of skin cancer.

Advanced practice providers will gather September 12 for a full-day program covering skin cancer prevention, diagnosis, staging, treatment, and procedural skills.

Robert R. Redfield, MD, will help guide development of GX-03 as Turn Therapeutics advances its phase 2 atopic dermatitis program.

FDA granted QRX003 RPD designation for PSS, adding to its Netherton syndrome designation as Quoin prepares for a phase 2 study.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.

A teen with persistent atopic dermatitis has tried multiple topicals but wants to avoid injectables. Work through the case and decide whether you would try another topical or escalate treatment.

AbbVie completed its $10.9 billion Apogee acquisition, adding IL-13 antibody zumilokibart and other inflammatory disease assets.

J. Caleb Runyon, NP-C, shares how he turned an unmet need into The Closer Look Project and what he learned along the way.

ACP outlines ethical AI in medicine: protect patient trust, fight bias, avoid deskilling, and disclose AI use as dermatology adopts new tools.

A twice-rejected melanoma immunotherapy finally won accelerated approval, acne's decades-long innovation drought moved a step closer to ending, and 2 rare, sun-triggered skin diseases picked up a deep-pocketed new sponsor.

Week 52 data show ixekizumab plus tirzepatide sustained or improved disease activity and metabolic outcomes in psoriasis and psoriatic arthritis.

Lisa Weiss, PA, discussed timely immunodermatology education, standout sessions, and the collaborative community at Elevate-Derm.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Test your knowledge of YCANTH and its phase 3 development program for common warts, including its current indication and COVE trials.

Shawn Demehri, MD, PhD, discussed immunomodulatory and antigen-directed immunotherapy approaches for skin cancer prevention in a recent Dermatology Times interview.

Jennifer Soung, MD, discusses whole patient care for psoriasis and alopecia areata and why setting realistic expectations matters for hair regrowth.

Shawn Demehri, MD, PhD, discusses a calcipotriene/5-FU combination immunotherapy for field cancerization and its potential in organ transplant recipients.

Eileen Cheever, MPAS, PA-C, discussed patient advocacy, mentorship, and improving dermatologic care across different stages of life.

Kimberly Madison, DNP, discussed how dermatology education can help nurses strengthen documentation, patient education, triage, and access to care.

Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.

Hair transplantation is expanding beyond scalp restoration. Here’s what NPs and PAs should know about candidacy, counseling, and recovery.

Daniel Butler, MD, shares practical considerations for NPs and PAs treating psoriasis in older adults, from counseling to treatment access.

Justin Love, PA, discussed the role of emotional intelligence, communication, and preparation when navigating difficult patient conversations.

Quoin reported positive interim phase 2/3 results for QRX003, which met the primary endpoint in patients with Netherton syndrome.

Paul Rose, MD, JD, discusses nonscalp hair transplantation, patient selection, common misconceptions, and the future of hair restoration.

Shawn Demehri, MD, PhD, discussed a topical combination immunotherapy being studied for skin cancer prevention in high-risk patients.